Body Iron Stores , Infection , and Risk of Acute Myocardial Infarction
暂无分享,去创建一个
L. Cobb | A. Hallstrom | A. d'Avila | Y. Doi | H. Kitaoka | N. Hitomi | M. Pecková
[1] P. Ridker,et al. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. , 1998, Circulation.
[2] Y. Nishizawa,et al. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. , 1998, Circulation.
[3] I. Pörsti,et al. Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro. , 1998, Pharmacology & toxicology.
[4] M. Komajda,et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. , 1998, European heart journal.
[5] C. Fahrenbruch,et al. Circadian variations in the occurrence of cardiac arrests: initial and repeat episodes. , 1998, Circulation.
[6] M. Komajda,et al. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. , 1998, Circulation.
[7] H Niimura,et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.
[8] J. Salonen. Excessive intake of iron and mercury in cardiovascular disease. , 1998, Bibliotheca nutritio et dieta.
[9] J. Raulston. Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins , 1997, Infection and immunity.
[10] J. Manson,et al. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. , 1997, Circulation.
[11] M. Matsuzaki,et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.
[12] M. Komajda,et al. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. , 1997, Journal of molecular and cellular cardiology.
[13] V. Fuster,et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. , 1996, Circulation.
[14] T. Imaizumi,et al. Disappearance of giant negative T waves in patients with the Japanese form of apical hypertrophy. , 1995, Journal of the American College of Cardiology.
[15] L. Demer. A skeleton in the atherosclerosis closet. , 1995, Circulation.
[16] P. Brugada,et al. At what time are implantable defibrillator shocks delivered? Evidence for individual circadian variance in sudden cardiac death. , 1995, European heart journal.
[17] M. Josephson,et al. Sudden cardiac death, circadian rhythms and defibrillators. , 1995, European heart journal.
[18] D. Bagchi,et al. Oxidative mechanisms in the toxicity of metal ions. , 1995, Free radical biology & medicine.
[19] H. Leclerc,et al. Iron acquisition by Helicobacter pylori: importance of human lactoferrin , 1993, Infection and immunity.
[20] D. Kramsch. Calcium antagonists and atherosclerosis. , 1985, Advances in experimental medicine and biology.
[21] D. Kramsch,et al. Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids. , 1981, Science.